Comparative Effectiveness of Tocilizumab and TNF Inhibitors in Rheumatoid Arthritis Patients: Data from the Rheumatic Diseases Portuguese Register, Reuma.pt

Figure 3

Low disease activity at 6 months according to treatment (a) and previous biologic therapy (b). (a) Significantly more patients treated with TCZ reached a state of at least DAS28 low disease activity (LDA), with no significant differences for CDAI and SDAI cutoffs. (b) Biologic-naïve patients in the TCZ group had significantly higher proportions of DAS28, CDAI, and SDAI LDA compared to TNFi users. On the contrary, in patients previously exposed to at least 1 biologic the frequencies of LDA according to all indexes were similar between drug class groups. value significant at <0.05.

(a)

(b)